Why SGPT and SGOT Are Elevated in Liver Injury
SGPT (ALT) and SGOT (AST) are elevated in liver injury because hepatocellular damage and necrosis cause these intracellular enzymes to leak from damaged liver cells directly into the bloodstream. 1
Mechanism of Enzyme Release
When hepatocytes are injured or undergo necrosis, their cell membranes lose integrity, allowing these aminotransferases—which are normally concentrated inside liver cells—to escape into the serum. Both AST and ALT are highly concentrated in the liver, making their elevations indicative of liver damage 1. This leakage occurs in response to:
- Diffuse hepatic infiltration (fat, copper, or iron)
- Acute hepatitis (viral, autoimmune, or drug-induced)
- Toxic injury (medications, alcohol, herbal supplements)
- Ischemic injury (shock liver, Budd-Chiari syndrome)
- Chronic liver diseases (cirrhosis, steatohepatitis)
Key Differences Between ALT and AST
ALT elevations are highly specific for liver injury because this enzyme exists in very low concentrations in skeletal muscle and kidney 1. This makes ALT the more reliable marker when you suspect hepatocellular damage.
AST is less specific because it can be elevated from non-hepatic sources including:
- Heart (myocardial infarction)
- Skeletal muscle (rhabdomyolysis, strenuous exercise)
- Kidneys
- Brain
- Red blood cells (hemolysis) 1
Clinical Interpretation Pattern
The pattern of elevation matters clinically:
- Hepatocellular injury pattern: Aminotransferases elevated much higher than alkaline phosphatase, directly reflecting hepatocyte damage 1
- AST:ALT ratio >2: Suggests alcoholic liver disease 1
- AST:ALT ratio <1: Suggests metabolic/nonalcoholic fatty liver disease 1
Severity Classification
The magnitude of elevation indicates injury severity 1:
- Mild: <5 times upper reference limit
- Moderate: 5-10 times upper reference limit
- Severe: >10 times upper reference limit
Important Caveats
The degree of enzyme elevation does not necessarily correlate with liver function or prognosis 2. A patient can have massive transaminase elevations (thousands) in acute viral hepatitis yet recover completely, while someone with cirrhosis may have only mild elevations but severe synthetic dysfunction. The enzymes measure hepatocyte injury, not hepatic synthetic capacity—albumin and prothrombin time actually measure liver function 1, 3.
In advanced liver disease like cirrhosis, GPT (ALT) activity decreases more than GOT (AST) in the liver itself, leading to a higher AST:ALT ratio even though overall enzyme levels may be only mildly elevated 4. This reflects a specific mechanism associated with hepatic injury progression rather than simple enzyme leakage.